False negative rate of COVID-19 PCR testing: a discordant testing analysis.

False negative rate of COVID-19 PCR testing: a discordant testing analysis.
复制标题

DOI:
10.1186/s12985-021-01489-0
复制
发表时间:
2021-01-09
期刊:
影响因子:
4.8
通讯作者:
Tipples G
Tipples G
中科院分区:
医学3区
文献类型:
--
作者:
Kanji JN;Zelyas N;MacDonald C;Pabbaraju K;Khan MN;Prasad A;Hu J;Diggle M;Berenger BM;Tipples G

文献摘要

参考文献

被引文献

相似文献

COVID-19是通过使用真实的时间逆转录聚合酶链反应(rtRT-PCR)检测SARS-CoV-2 RNA来诊断的。由于缺乏金标准,许多SARS-CoV-2 rt-PCR检测的性能尚不完全清楚。我们试图评估我们实验室开发的靶向包膜(E)和RNA依赖性RNA聚合酶(RdRp)基因的SARS-CoV-2 rtRT-PCR的假阴性率(FNR)和灵敏度。对2020年1月21日至4月18日公共卫生实验室(加拿大阿尔伯塔)的SARS-CoV-2 rt-PCR结果进行了审查,以确定初始rt-PCR阴性,随后在14天内重复检测结果为阳性的患者(定义为不一致结果)。使用三种替代rtRT-PCR检测试剂(靶向核衣壳基因的E基因和N1/N2区域)对这些不一致标本的阴性样本进行复检,以评估假阴性(FN)结果。在规定的时间段内,95,919名患者(100,001份样本)接受了SARS-CoV-2检测。其中,发现49例患者的结果不一致,包括49例阳性和52例阴性拭子。对52份阴性拭子进行重复检测,发现5个FN(来自5名不同患者)。假设诊断检测的特异性为100%,则该组不一致检测患者的FNR和灵敏度分别为9.3%(95% CI 1.5-17.0%)和90.7%(95% CI 82.6-98.9%)。了解常规使用的检测试剂盒的FNR的研究对于确认充分的临床性能非常重要。在这项研究中,大多数FN结果是由于在感染的不同阶段收集了多份标本的患者中SARS-CoV-2病毒浓度较低。建议对每位患者进行检测后临床评估,以确保rtRT-PCR结果不是排除COVID-19的唯一因素。
COVID-19 is diagnosed via detection of SARS-CoV-2 RNA using real time reverse-transcriptase polymerase chain reaction (rtRT-PCR). Performance of many SARS-CoV-2 rtRT-PCR assays is not entirely known due to the lack of a gold standard. We sought to evaluate the false negative rate (FNR) and sensitivity of our laboratory-developed SARS-CoV-2 rtRT-PCR targeting the envelope (E) and RNA-dependent RNA-polymerase (RdRp) genes. SARS-CoV-2 rtRT-PCR results at the Public Health Laboratory (Alberta, Canada) from January 21 to April 18, 2020 were reviewed to identify patients with an initial negative rtRT-PCR followed by a positive result on repeat testing within 14 days (defined as discordant results). Negative samples from these discordant specimens were re-tested using three alternate rtRT-PCR assays (targeting the E gene and N1/N2 regions of the nucleocapsid genes) to assess for false negative (FN) results. During the time period specified, 95,919 patients (100,001 samples) were tested for SARS-CoV-2. Of these, 49 patients were found to have discordant results including 49 positive and 52 negative swabs. Repeat testing of 52 negative swabs found five FNs (from five separate patients). Assuming 100% specificity of the diagnostic assay, the FNR and sensitivity in this group of patients with discordant testing was 9.3% (95% CI 1.5–17.0%) and 90.7% (95% CI 82.6–98.9%) respectively. Studies to understand the FNR of routinely used assays are important to confirm adequate clinical performance. In this study, most FN results were due to low amounts of SARS-CoV-2 virus concentrations in patients with multiple specimens collected during different stages of infection. Post-test clinical evaluation of each patient is advised to ensure that rtRT-PCR results are not the only factor in excluding COVID-19.
DOI: 10.2196/19054
发表时间: 2020-04-24
影响因子: 8.5
作者:
Sullivan, Patrick Sean;Sailey, Charles;Sanchez, Travis Howard
通讯作者: Sanchez, Travis Howard
DOI: 10.1093/cid/ciaa722
发表时间: 2021-01-15
影响因子: 11.8
作者:
Long, Dustin R.;Gombar, Saurabh;Sunshine, Jacob E.
通讯作者: Sunshine, Jacob E.
DOI: 10.1093/clinchem/hvaa091
发表时间: 2020-06-01
期刊: CLINICAL CHEMISTRY
影响因子: 9.3
作者:
Pan, Yang;Long, Luyao;Ren, Simei
通讯作者: Ren, Simei
DOI: 10.1371/journal.pone.0242958
发表时间: 2020
期刊: PloS one
影响因子: 3.7
作者:
Arevalo-Rodriguez I;Buitrago-Garcia D;Simancas-Racines D;Zambrano-Achig P;Del Campo R;Ciapponi A;Sued O;Martinez-García L;Rutjes AW;Low N;Bossuyt PM;Perez-Molina JA;Zamora J
通讯作者: Zamora J
DOI: 10.1093/cid/ciaa848
发表时间: 2021-03-15
影响因子: 11.8
作者:
Jamal, Alainna J.;Mozafarihashjin, Mohammad;Mubareka, Samira
通讯作者: Mubareka, Samira